124 related articles for article (PubMed ID: 26462285)
21. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.
Frank B; Ariza L; Lamparter H; Grossmann V; Prochaska JH; Ullmann A; Kindler F; Weisser G; Walter U; Lackner KJ; Espinola-Klein C; Münzel T; Konstantinides SV; Wild PS;
BMJ Open; 2015 Jul; 5(7):e008157. PubMed ID: 26133379
[TBL] [Abstract][Full Text] [Related]
22. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011.
Ording AG; Horváth-Puhó E; Lash TL; Ehrenstein V; Borre M; Vyberg M; Sørensen HT
Cancer; 2015 Oct; 121(20):3692-9. PubMed ID: 26149752
[TBL] [Abstract][Full Text] [Related]
24. [The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use?].
Malý R; Vodicková L
Vnitr Lek; 2004 Oct; 50(10):751-5. PubMed ID: 15633930
[TBL] [Abstract][Full Text] [Related]
25. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients.
Aldawood A; Arabi Y; Aljumah A; Alsaadi A; Rishu A; Aldorzi H; Alqahtani S; Alsultan M; Felemban A
Thromb J; 2011 Jan; 9(1):1. PubMed ID: 21244669
[TBL] [Abstract][Full Text] [Related]
26. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
[TBL] [Abstract][Full Text] [Related]
27. Venous thrombosis and risk of cancer in patients with arterial cardiovascular disease.
Schmidt SA; Farkas DK; Pedersen L; Prandoni P; Sørensen HT
Thromb Res; 2015 Jan; 135(1):96-101. PubMed ID: 25467083
[TBL] [Abstract][Full Text] [Related]
28. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study.
Søgaard KK; Horváth-Puhó E; Grønbaek H; Jepsen P; Vilstrup H; Sørensen HT
Am J Gastroenterol; 2009 Jan; 104(1):96-101. PubMed ID: 19098856
[TBL] [Abstract][Full Text] [Related]
29. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic venous thromboembolism: a potential surrogate for occult cancer.
Chung WS; Lin CL; Hsu WH; Sung FC; Li RY; Kao CH
QJM; 2014 Jul; 107(7):529-36. PubMed ID: 24472734
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Eur Heart J; 2011 Nov; 32(22):2800-5. PubMed ID: 21750095
[TBL] [Abstract][Full Text] [Related]
32. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort.
Tagalakis V; Patenaude V; Kahn SR; Suissa S
Am J Med; 2013 Sep; 126(9):832.e13-21. PubMed ID: 23830539
[TBL] [Abstract][Full Text] [Related]
33. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort.
Ahern TP; Horváth-Puhó E; Spindler KL; Sørensen HT; Ording AG; Erichsen R
Br J Cancer; 2016 Jan; 114(1):96-102. PubMed ID: 26625005
[TBL] [Abstract][Full Text] [Related]
35. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
36. PO-06 - Cancer and the risk of venous thromboembolism in stroke patients.
Corraini P; Ording AG; Henderson VW; Szépligeti S; Hováth-Puhó E; Sørensen HT
Thromb Res; 2016 Apr; 140 Suppl 1():S178. PubMed ID: 27161694
[TBL] [Abstract][Full Text] [Related]
37. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
38. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
[TBL] [Abstract][Full Text] [Related]
39. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.
Stine JG; Niccum BA; Zimmet AN; Intagliata N; Caldwell SH; Argo CK; Northup PG
Clin Transl Gastroenterol; 2018 Mar; 9(3):140. PubMed ID: 29511162
[TBL] [Abstract][Full Text] [Related]
40. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
